Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE:002675)

Market Cap	10.30B -13.9%
Revenue (ttm)	2.68B -7.8%
Net Income	204.33M +41.7%
EPS	0.25 +41.6%
Shares Out	824.60M
PE Ratio	50.43
Forward PE	31.62
Dividend	0.08 (0.65%)
Ex-Dividend Date	Apr 29, 2026

Volume	6,327,724
Open	12.40
Previous Close	12.31
Day's Range	12.23 - 12.54
52-Week Range	12.12 - 18.68
Beta	-0.08
Analysts	Buy
Price Target	18.73 (+49.96%)
Earnings Date	Aug 14, 2026

About SHE:002675

Yantai Dongcheng Pharmaceutical Group Co.,Ltd. engages in the raw materials, formulations, nuclear medicine, and big health businesses in China and internationally. It operates through API, Formulation, Radio Pharmaceutical, and Others segments. The company offers formulation products, such as powder injections, tablets, capsules, granules, and drop pills for anticoagulation, cardiovascular, anti-tumor, urology, orthopedics, and anti-infection applications. It also provides active pharmaceutical ingredients, including heparin, chondroitin sulfa...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Employees: 2,583
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002675

Financial Performance

In 2025, SHE:002675's revenue was 2.74 billion, a decrease of -4.46% compared to the previous year's 2.87 billion. Earnings were 195.63 million, an increase of 6.42%.

Analyst Summary

According to 3 analysts, the average rating for 002675 stock is "Buy." The 12-month stock price target is ¥18.73, which is an increase of 49.96% from the latest price.

Price Target

¥18.73

(49.96% upside)

Analyst Consensus: Buy